MEAGAN FANSLER: Open Payments
NPI 1720715485 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,738 in 82 payments from 22 companies in 2025. Trend: 2023 $2,079 · 2024 $2,285 · 2025 $1,738
Food & beverage: $1,678Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $449 |
| Regeneron Healthcare Solutions, Inc. | 8 | $240 |
| Viatris Specialty LLC | 11 | $211 |
| GENZYME CORPORATION | 10 | $187 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| United Therapeutics Corporation | 5 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $60 |
| Grifols USA, LLC | 3 | $55 |
| JAZZ PHARMACEUTICALS INC. | 3 | $49 |
| Genentech USA, Inc. | 2 | $47 |
Products named: DUPIXENT, YUPELRI, BREZTRI, FASENRA, TEZSPIRE, NUCALA, Tyvaso, Prolastin-C Liquid.
Industry payments across MO — which companies pay providers there.
